Prostate cancer is a very common disease. Studies of men without clinical evidence of prostate cancer, but who later died of accident or injury, have found that many men had prostate cancer and simply didn’t know it.
A man’s risk of prostate cancer being present somewhere in his prostate is approximately his age, minus 10, as a percent. Thus, a 60-year-old man has about a 50-50 chance of having some amount of prostate cancer within his prostate gland. On the other hand, a man’s lifetime risk of dying of prostate cancer is between two and four percent.
Most prostate cancers will never cause a problem during a man’s life. The prostate cancers most likely to cause problems are those that are large and those which are aggressive in appearance when examined under a microscope.
Why choose the Cancer Therapy & Research Center (CTRC) for prostate cancer?
The physicians who treat prostate cancer at the Cancer Therapy & Research Center (CTRC) are known around the world as experts in the management of this disease. We are the only National Cancer Institute (NCI) designated cancer center in Central and South Texas. Patients worldwide seek care at the CTRC due to the significant expertise of our physicians as well as their understanding that many of the current treatments around the world were developed here at the CTRC by our physicians. Examples of just a few of these discoveries include:
- The two largest studies for prevention of prostate cancer were developed and overseen by faculty members of the CTRC. These two studies demonstrated that finasteride reduced the risk of prostate cancer by about 30 percent, that vitamin E increased the risk of prostate cancer by 17 percent and that selenium had no beneficial effect. Physicians at the CTRC are thus well informed to have high-level discussions with patients about methods to reduce their risk of prostate cancer.
- The Prostate Cancer Prevention Trial Risk Calculator was developed at the CTRC in collaboration with individuals from around the world. This tool is used in almost every clinic around the world to help men determine their personalized risk of prostate cancer. Due to this special expertise, the CTRC physicians are specialists in assisting patients in understanding their risk of prostate cancer before they undergo a prostate biopsy. Given the individualized nature of the Risk Calculator, it is a common occurrence that patients who have been recommended to undergo a prostate biopsy by another physician, after viewing their own risk, opt instead to monitor their risk.
- The CTRC physicians have led a number of major treatment trials for prostate cancer over the past several decades. These studies have been incorporated into national and international treatment guidelines that specify how the disease should be treated. Patients coming to the CTRC will see a specialist in genitourinary oncology and may see multiple specialists to develop an individualized treatment plan that is based on the most current management guidelines.
Clinical trials at the CTRC
An advantage of receiving care from the prostate cancer specialists at the CTRC is that they can offer opportunities for new cancer treatments, cancer detection tests and methods to reduce the risk of cancer development or recurrence. Take a look at the available clinical trials at the CTRC.
Make an appointment
To request an appointment with our team or to make a referral to one of our physicians, please call the CTRC main number: (210) 450-1000 or 800-340-2872 or email CTRCReferral@uthscsa.edu.